Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Ross Simcoe

Emergency Medicine Philadelphia, PA Medical Doctor

NPI 1801138193 CMS profile 1614453

111 S 11Th St, Philadelphia, PA 19107

Open in the dashboard

General payments

$15,719

45 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Ross Simcoe of Philadelphia, PA is reported in the CMS Open Payments database as having received $15,719 across 45 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $32 2
2020 General $4,642 16
2019 General $11,045 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ross Simcoe
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Ross Simcoe were reported at $0. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Ross Simcoe Emergency Medicine median Middle half National median
2019 $11,045 $51 $18–$128 $163
2020 $4,642 $29 $16–$99 $114
2021 $0 $40 $18–$124 $132
2022 $0 $49 $20–$134 $149
2023 $32 $51 $22–$142 $160
2024 $0 $52 $22–$150 $164
2025 $0 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Vapotherm Inc $15,670 42 payments
  2. CSL Behring $50 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $12,963 12 payments
  2. Travel and Lodging $2,350 19 payments
  3. Food and Beverage $397 13 payments
  4. Gift $10 1 payment
Products named General payments · program years 2019–2023
  1. Precision Flow $15,670 42 payments
  2. Kcentra $50 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

399

Median for Emergency Medicine: 88

Drug cost

$2,533

Median for Emergency Medicine: $590

Branded share of claims

24.6%

Median for Emergency Medicine: 33.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Albuterol Sulfate Hfa Albuterol Sulfate Brand 17 $513
Ondansetron Odt Ondansetron Brand 43 $427
Cefuroxime Cefuroxime Axetil Brand 22 $303
Cephalexin Generic 56 $232
Naproxen Generic 29 $176
Doxycycline Hyclate Generic 25 $159
Ibuprofen Generic 42 $147
Prednisone Generic 50 $125
Cyclobenzaprine Hcl Generic 28 $101
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 16 $95

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$106,945

Medicare's payments for the services billed

Medicare patients

631

Average age 74

Services billed

1,032

332 women, 299 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 48%
Chronic kidney disease 47%
Diabetes 46%
Heart failure 43%
Atrial fibrillation 39%
Depression 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

45 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record